Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
hyaluronic acid (3 trials)
xg-104 (1 trial)
Cataract (Phase 3)
Dry Eye Syndromes (Phase 2)
Inflammation (Phase 3)
Keratoconjunctivitis Sicca (Phase 2)
Uveitis (Phase 3)
Trials (4 total)
Trial APIs (2 total)